APA (7th ed.) Citation

J, S., F, M., M, G. d. S., F, F., J, D., YM, B., . . . OA, C. (2023). Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: A report from the EPICOVIDEHA registry. EClinicalMedicine, 58, 101939. https://doi.org/10.1016/j.eclinm.2023.101939

Chicago Style (17th ed.) Citation

J, Salmanton-García, et al. "Nirmatrelvir/ritonavir in COVID-19 Patients with Haematological Malignancies: A Report from the EPICOVIDEHA Registry." EClinicalMedicine 58 (2023): 101939. https://doi.org/10.1016/j.eclinm.2023.101939.

MLA (9th ed.) Citation

J, Salmanton-García, et al. "Nirmatrelvir/ritonavir in COVID-19 Patients with Haematological Malignancies: A Report from the EPICOVIDEHA Registry." EClinicalMedicine, vol. 58, 2023, p. 101939, https://doi.org/10.1016/j.eclinm.2023.101939.